SCHEMBL2608231

SCHEMBL2608231

C=CC(=O)NCCCCOC(C)C

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ZDHHC20 Q5W0Z9 1/20 0.56
ZDHHC2 Q9UIJ5 1/20 0.56
ALDH1A1 P00352 3/20 0.50
TSHR P16473 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 2/20 0.41
GAA P10253 2/20 0.41
TGM2 P21980 2/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
EPHX2 P34913 1/20 0.39
TP53 P04637 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2608229 0.98 ZDHHC20 (0.59) ZDHHC20ZDHHC2ALDH1A1TSHRL3MBTL1
SCHEMBL3109503 0.95 ALDH1A1 (0.56) ZDHHC20ZDHHC2ALDH1A1TSHRL3MBTL1
SCHEMBL12332784 0.89 ZDHHC20 (0.49) ZDHHC20ZDHHC2ALDH1A1TSHRL3MBTL1
SCHEMBL12304713 0.89 ZDHHC20 (0.45) ZDHHC20ZDHHC2ALDH1A1TSHRL3MBTL1
SCHEMBL2608232 0.87 ZDHHC20 (0.47) ZDHHC20ZDHHC2ALDH1A1TSHRL3MBTL1
SCHEMBL25521272 0.84 ZDHHC20 (0.53) ZDHHC20ZDHHC2ALDH1A1TSHRL3MBTL1
SCHEMBL1994080 0.84 ZDHHC20 (0.53) ZDHHC20ZDHHC2ALDH1A1TSHRL3MBTL1
SCHEMBL2608177 0.83 ZDHHC20 (0.56) ZDHHC20ZDHHC2ALDH1A1TSHRGAA
SCHEMBL22840975 0.82 TSHR (0.50) ZDHHC20ZDHHC2ALDH1A1TSHRTGM2
SCHEMBL2608197 0.81 ZDHHC20 (0.59) ZDHHC20ZDHHC2ALDH1A1TSHRTGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8262932-B2 Polymerizable liquid crystal compound, polymerizable liquid crystal composition, polymer and film FUJIFILM CORPORATION (JP) 2012-09-11 US disclosed
US-8158021-B2 Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystalline polymer, and optical anisotropic article ZEON CORPORATION (JP) 2012-04-17 US disclosed
US-20100258764-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTALLINE POLYMER, AND OPTICAL ANISOTROPIC ARTICLE ZEON CORPORATION (JP) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100258764-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTALLINE POLYMER, AND OPTICAL ANISOTROPIC ARTICLE LEO1, ZYX, CCNT1 ZDHHC20 1156/4885ZDHHC2 565/4885ALDH1A1 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.